Isofol - Investing in Life Science Biostock September 22, 2026

Isofol's CEO Petter Segelman Lindqvist presents the company and why improving the backbone of colorectal cancer treatment may represent one of the largest opportunities to improve outcomes for patients, both today and in the years ahead.